Kolexia
Chevalier Simon Pharmacien
Chevalier Simon
Pharmacien
Hôpital Nord Grenoble
La Tronche, France
32 Activités
74 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Préleucémie Syndromes myélodysplasiques Leucémie aigüe myéloïde Leucémie myéloïde Leucémie myélomonocytaire juvénile Lymphomes Inflammation Leucémie myélomonocytaire chronique

Collaborateurs

Voir plus
Lefebvre Christine
Lefebvre Christine
Hôpital Nord Grenoble, La Tronche, France
Jacob Marie-Christine
Jacob Marie-Christine
Hôpital Nord Grenoble, La Tronche, France
Vettier Claire
Vettier Claire
Hôpital Nord Grenoble, La Tronche, France
Raskovalova Tatiana
Raskovalova Tatiana
Hôpital Nord Grenoble, La Tronche, France

Industries

Voir plus
Sanofi
1 collaboration(s)
Dernière en 2021
Novartis
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MPO-MDS-Develp: Development and Prospective Validation of a Standardized Flow Cytometric Assay of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes.
Essai Clinique (CHU Grenoble)   18 mars 2024
White blood cells scattergram as a valuable tool for COVID-19 screening: A multicentric study.
International journal of laboratory hematology   04 mars 2024
Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.
PloS one   18 novembre 2022
Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study.
BMJ open   07 octobre 2022
Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning.
Haematologica   01 juin 2022
AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.
Hematology (Amsterdam, Netherlands)   31 mai 2022
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.
Cancers   24 novembre 2021
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
The journal of pathology. Clinical research   09 août 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies.
British journal of haematology   21 juin 2021
Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
HemaSphere   12 juin 2021